Kathryn W. Schenck

In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides.

Raymond F. Kauffman, Kathryn W. Schenck, B G Utterback et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 124 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine

Frank P. Bymaster, Julie F. Falcone, Delbert Bauzon et al. · European Journal of Pharmacology · 2001 · 123 citations

Medicine, Pharmacology, Pharmacotherapy +13

Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.

David B. Wainscott, Marlene L. Cohen, Kathryn W. Schenck et al. · Molecular Pharmacology · 1993 · 116 citations

Medicine, Biochemistry, Pharmacology +15

Role of 5-HT2 receptors in serotonin-induced contractions of nonvascular smooth muscle.

Marlene L. Cohen, Kathryn W. Schenck, Walter E. Colbert et al. · Journal of Pharmacology and Experimental Therapeutics · 1985 · 81 citations

Medicine, Pharmacology, Physiology +15

Pharmacological Characterization of the Competitive GLUK5 Receptor Antagonist Decahydroisoquinoline LY466195 in Vitro and in Vivo

Brianne Weiss, Andrew Alt, Ann Marie L. Ogden et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 74 citations · Full text

Life Sciences, Neuroscience, Pharmacology +16